Effects of early intervention with epoetin alfa on transfusion requirement, hemoglobin level and survival during platinum-based chemotherapy: Results of a multicenter randomised controlled trial
- 31 July 2005
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 41 (11) , 1560-1569
- https://doi.org/10.1016/j.ejca.2005.03.024
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Weekly Epoetin Alfa Maintains Hemoglobin, Improves Quality of Life, and Reduces Transfusion in Breast Cancer Patients Receiving ChemotherapyJournal of Clinical Oncology, 2005
- Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trialThe Lancet, 2003
- O-253 Early intervention with epoetin alfa maintains hemoglobin (HB) in advanced non-small-cell lung cancer (NSCLC) patientsLung Cancer, 2003
- O-252 Effects of early intervention with epoetin alfa in patients with small cell lung cancer (SCLC)Lung Cancer, 2003
- Erythropoietin regulates tumour growth of human malignanciesCarcinogenesis: Integrative Cancer Research, 2003
- Association between smoking during radiotherapy and prognosis in head and neck cancer: A follow‐up studyHead & Neck, 2002
- Immunohistochemical expression of erythropoietin and erythropoietin receptor in breast carcinomaCancer, 2002
- Relationship between changes in hemoglobin level and quality of life during chemotherapy in anemic cancer patients receiving epoetin alfa therapyCancer, 2002
- Randomized, Double-Blind, Placebo-Controlled Trial of Recombinant Human Erythropoietin, Epoetin Beta, in Hematologic MalignanciesJournal of Clinical Oncology, 2002
- Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement systemJournal of Pain and Symptom Management, 1997